RNA interference for the treatment of heart failure

Details for Australian Patent Application No. 2008346801 (hide)

Owner Nanocor Therapeutics, Inc.

Inventors Hajjar, Roger J.; Poller, Wolfgang Ch.; Fechner, Henry

Agent Shelston IP

Pub. Number AU-A-2008346801

PCT Pub. Number WO2009/088786

Priority 61/018,326 31.12.07 US

Filing date 23 December 2008

Wipo publication date 16 July 2009

International Classifications

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/088786 Priority application(s): WO2009/088786

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008346817-Substantially animal protein-free recombinant furin and methods for producing same

2008346799-Acetylene enhanced conversion of syngas to Fischer-Tropsch hydrocarbon products